iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Twin Focus Capital Partners LLC

Twin Focus Capital Partners LLC cut its position in iShares Biotechnology ETF (NASDAQ:IBB) by 11.4% during the fourth quarter, Holdings Channel reports. The firm owned 10,847 shares of the financial services provider’s stock after selling 1,399 shares during the period. Twin Focus Capital Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,434,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Proficio Capital Partners LLC purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter worth about $480,000. IFP Advisors Inc grew its stake in shares of iShares Biotechnology ETF by 237.1% during the 4th quarter. IFP Advisors Inc now owns 16,018 shares of the financial services provider’s stock worth $2,118,000 after purchasing an additional 11,266 shares during the period. FineMark National Bank & Trust purchased a new position in shares of iShares Biotechnology ETF during the 4th quarter valued at approximately $319,000. Cullen Frost Bankers Inc. lifted its stake in shares of iShares Biotechnology ETF by 1.5% in the 4th quarter. Cullen Frost Bankers Inc. now owns 5,654 shares of the financial services provider’s stock valued at $748,000 after purchasing an additional 82 shares during the period. Finally, Modern Wealth Management LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter worth $237,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

IBB opened at $119.85 on Wednesday. The company has a fifty day moving average of $130.88 and a two-hundred day moving average of $136.32. The stock has a market capitalization of $5.36 billion, a price-to-earnings ratio of 24.21 and a beta of 0.84. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Increases Dividend

The firm also recently declared a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were paid a $0.1212 dividend. The ex-dividend date of this dividend was Tuesday, March 18th. This is a positive change from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.